However, it was noted that a vaccine would not be available to most of the population until the middle of the following year.
"We want a safe and effective vaccine, not necessarily to be the first," Spahn said.
Karliczek, in her turn, added that safety had absolute priority on that point.
As we reported earlier, on August 27, the European Commission signed the first agreement for the purchase of 300 million doses of vaccine against the coronavirus.
The agreement provides the purchase of 300 million doses of vaccine for all countries-members of the European Union. The purchase of the next 100 million doses is also provided.
Moreover, the European Commission plans to sign similar agreements with another four developers – GSK, Johnson & Johnson, CureVac, and Moderna.
Meanwhile, the authorities of the Brazilian state Bahia signed the agreement on the holding of the third phase of clinical trials of the Russian Sputnik V vaccine against Covid-19.